GC Green Cross MS Turns Profitable in Q3 with 600 Million KRW Operating Profit
[Asia Economy, Reporter: Cho Hyun] On November 2, GC Green Cross MS announced in a provisional disclosure that its consolidated operating profit for the third quarter of this year reached 600 million KRW, turning to profit compared to the same period last year.
During the same period, sales increased by 60% to 29.8 billion KRW, and net profit for the quarter reached 500 million KRW, also turning to profit. These figures reflect the profit and loss from discontinued operations (blood bags).
GC Green Cross MS saw improved results as it maintained solid growth in its main business segments, including diagnostic devices and hemodialysis solutions. Since production began at the second Eumseong plant in May, the core hemodialysis solution business has grown by more than 10%.
In particular, it is analyzed that the continued overseas supply of COVID-19 diagnostic kits since the export contract was signed in June has driven performance growth.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
A representative from GC Green Cross MS stated, "The business restructuring that began last year is now resulting in stable performance. With the strong export of COVID-19 diagnostic kits added to our existing businesses, we expect even more positive results going forward."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
